Holding
In Univ. of Mass v. L'Oréal USA, Inc., No.
17-cv-0868 (D. Del. April 20, 2021), the district court judge
granted L'Oréal's motion for summary judgment of
invalidity for indefiniteness.
Background
UMass sued L'Oréal for infringement of U.S. Pat.
No. 6,423,327 (“the ‘327 patent”) and 6,645,513
(“the ‘513 patent”). Claim 1 in each read:
[a] method for enhancing the condition of unbroken skin of a
mammal by reducing one or more of wrinkling, roughness, dryness, or
laxity of the skin, without increasing dermal cell proliferation,
the method comprising topically applying to the skin a
composition comprising a concentration of adenosine in an
amount effective to enhance the condition of the skin without
increasing dermal cell proliferation, wherein the adenosine
concentration applied to the dermal cells is [a recited
concentration range].